메뉴 건너뛰기




Volumn 12, Issue 11, 2005, Pages 10-13

Protecting the blind

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

EID: 27944455305     PISSN: 13500961     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (5)

References (5)
  • 1
    • 0142237814 scopus 로고    scopus 로고
    • 'Using IVRS in clinical trial management'
    • B Byrom. 'Using IVRS in clinical trial management', Applied Clinical Trials, 10, pp36-42, 2002.
    • (2002) Applied Clinical Trials , vol.10 , pp. 36-42
    • Byrom, B.1
  • 2
    • 0012214729 scopus 로고    scopus 로고
    • 'Intelligent medication management- using IVR to optimise the drug supply process'
    • Summer
    • N Dowlman. 'Intelligent medication management- using IVR to optimise the drug supply process', Pharmaceutical Manufacturing and Packing Sourcer, Summer, pp24-28, 2001.
    • (2001) Pharmaceutical Manufacturing and Packing Sourcer , pp. 24-28
    • Dowlman, N.1
  • 3
    • 0012185563 scopus 로고    scopus 로고
    • 'The cost benefits of using IVR systems in the supply chain'
    • Autumn
    • N Dowlman. 'The cost benefits of using IVR systems in the supply chain', Pharmaceutical Manufacturing and Packing Sourcer, Autumn, pp74-79,2001.
    • (2001) Pharmaceutical Manufacturing and Packing Sourcer , pp. 74-79
    • Dowlman, N.1
  • 4
    • 0035380351 scopus 로고    scopus 로고
    • 'Letter to the Editor'
    • S Day. 'Letter to the Editor', Controlled Clinical Trials, 22(3), pp264-265, 2001.
    • (2001) Controlled Clinical Trials , vol.22 , Issue.3 , pp. 264-265
    • Day, S.1
  • 5
    • 0035150507 scopus 로고    scopus 로고
    • 'Why permutation is even more important in IVRS drug codes schedule generation than in patient randomisation schedule generation'
    • Letter to the Editor
    • OM Kuznetsova. 'Why permutation is even more important in IVRS drug codes schedule generation than in patient randomisation schedule generation. Letter to the Editor', Controlled Clinical Trials, 22(1), pp69-71, 2001.
    • (2001) Controlled Clinical Trials , vol.22 , Issue.1 , pp. 69-71
    • Kuznetsova, O.M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.